Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real‐Life Cohort and Literature Review

Ofelia Baniandrés, Inmaculada Balaguer Franch, Eva Vilarrasa Rull, Adrián Imbernón Moya, María Luisa Alonso Pacheco, Almudena Mateu Puchades, Julia Paloma Hergueta Sánchez, Francisco Javier Mataix Díaz, Adrián Ballano Ruiz, Álvaro González Cantero, Elena Martínez Lorenzo, Manuel Galán Gutiérrez, Lourdes Rodríguez Fernández‐Freire, Aina Vila Payeras, Carlos Muñoz Santos, Pablo Hernández Bel, Sergio Hernández Ostiz, Josep Pujol Montcusí, Marcial Álvarez Salafranca, Pablo Coto Segura, Isabel Martínez Pallas, Antoni Azón Masoliver, Teresa Martínez Manchón, Carmen Delgado Mucientes, Constantin Luca Schneller‐Pavelescu Apetrei, Asunción Ballester Martínez, Juan Monte Serrano, Cristina Pindado Ortega, Leandra Reguero del Cura, Irene López Barragán, Eva Chavarría Mur, Mónica González Olivares, Pablo de la Cueva Dobao

Open source

DOI: 10.1111/ijd.70053
Published: 2025-09-10
Container: International Journal of Dermatology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ijd.70053,
  title = {Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real‐Life Cohort and Literature Review},
  author = {Ofelia Baniandrés and Inmaculada Balaguer Franch and Eva Vilarrasa Rull and Adrián Imbernón Moya and María Luisa Alonso Pacheco and Almudena Mateu Puchades and Julia Paloma Hergueta Sánchez and Francisco Javier Mataix Díaz and Adrián Ballano Ruiz and Álvaro González Cantero and Elena Martínez Lorenzo and Manuel Galán Gutiérrez and Lourdes Rodríguez Fernández‐Freire and Aina Vila Payeras and Carlos Muñoz Santos and Pablo Hernández Bel and Sergio Hernández Ostiz and Josep Pujol Montcusí and Marcial Álvarez Salafranca and Pablo Coto Segura and Isabel Martínez Pallas and Antoni Azón Masoliver and Teresa Martínez Manchón and Carmen Delgado Mucientes and Constantin Luca Schneller‐Pavelescu Apetrei and Asunción Ballester Martínez and Juan Monte Serrano and Cristina Pindado Ortega and Leandra Reguero del Cura and Irene López Barragán and Eva Chavarría Mur and Mónica González Olivares and Pablo de la Cueva Dobao},
  year = {2025},
  journal = {International Journal of Dermatology},
  doi = {10.1111/ijd.70053},
  url = {https://doi.org/10.1111/ijd.70053}
}

RIS

TY  - JOUR
TI  - Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real‐Life Cohort and Literature Review
AU  - Ofelia Baniandrés
AU  - Inmaculada Balaguer Franch
AU  - Eva Vilarrasa Rull
AU  - Adrián Imbernón Moya
AU  - María Luisa Alonso Pacheco
AU  - Almudena Mateu Puchades
AU  - Julia Paloma Hergueta Sánchez
AU  - Francisco Javier Mataix Díaz
AU  - Adrián Ballano Ruiz
AU  - Álvaro González Cantero
AU  - Elena Martínez Lorenzo
AU  - Manuel Galán Gutiérrez
AU  - Lourdes Rodríguez Fernández‐Freire
AU  - Aina Vila Payeras
AU  - Carlos Muñoz Santos
AU  - Pablo Hernández Bel
AU  - Sergio Hernández Ostiz
AU  - Josep Pujol Montcusí
AU  - Marcial Álvarez Salafranca
AU  - Pablo Coto Segura
AU  - Isabel Martínez Pallas
AU  - Antoni Azón Masoliver
AU  - Teresa Martínez Manchón
AU  - Carmen Delgado Mucientes
AU  - Constantin Luca Schneller‐Pavelescu Apetrei
AU  - Asunción Ballester Martínez
AU  - Juan Monte Serrano
AU  - Cristina Pindado Ortega
AU  - Leandra Reguero del Cura
AU  - Irene López Barragán
AU  - Eva Chavarría Mur
AU  - Mónica González Olivares
AU  - Pablo de la Cueva Dobao
PY  - 2025
JO  - International Journal of Dermatology
DO  - 10.1111/ijd.70053
UR  - https://doi.org/10.1111/ijd.70053
ER  -

APA

Baniandrés, O., Franch, I. B., Rull, E. V., Moya, A. I., Pacheco, M. L. A., Puchades, A. M., Sánchez, J. P. H., Díaz, F. J. M., Ruiz, A. B., Cantero, Á. G., Lorenzo, E. M., Gutiérrez, M. G., Fernández‐Freire, L. R., Payeras, A. V., Santos, C. M., Bel, P. H., Ostiz, S. H., Montcusí, J. P., Salafranca, M. Á., Segura, P. C., Pallas, I. M., Masoliver, A. A., Manchón, T. M., Mucientes, C. D., Apetrei, C. L. S., Martínez, A. B., Serrano, J. M., Ortega, C. P., Cura, L. R. D., Barragán, I. L., Mur, E. C., Olivares, M. G., & Dobao, P. D. L. C. (2025). Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real‐Life Cohort and Literature Review. International Journal of Dermatology. https://doi.org/10.1111/ijd.70053

Source records

crossref · retrieved 2026-09-26T23:30:09.518Z